Related references
Note: Only part of the references are listed.Targeted therapies in metastatic renal cancer in 2009
Laurence Bastien et al.
BJU INTERNATIONAL (2009)
Control of HIF-1α Expression by eIF2α Phosphorylation-Mediated Translational Repression
Keyi Zhu et al.
CANCER RESEARCH (2009)
Targeting Heat Shock Protein 90 Overrides the Resistance of Lung Cancer Cells by Blocking Radiation-Induced Stabilization of Hypoxia-Inducible Factor-1α
Woo-Young Kim et al.
CANCER RESEARCH (2009)
Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis
Erwan Pencreach et al.
CLINICAL CANCER RESEARCH (2009)
Role of the Phosphatidylinositol-3-Kinase and Extracellular Regulated Kinase Pathways in the Induction of Hypoxia-Inducible Factor (HIF)-1 Activity and the HIF-1 Target Vascular Endothelial Growth Factor in Ovarian Granulosa Cells in Response to Follicle-Stimulating Hormone
Hena Alam et al.
ENDOCRINOLOGY (2009)
NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway
Grant D. Stewart et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model
E. M. Hendriksen et al.
MICROVASCULAR RESEARCH (2009)
Small-Molecule Activation of p53 Blocks Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression In Vivo and Leads to Tumor Cell Apoptosis in Normoxia and Hypoxia
Jun Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Inhibition of Siah ubiquitin ligase function
A. Moller et al.
ONCOGENE (2009)
Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy
P. Garcia-Maceira et al.
ONCOGENE (2009)
Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis
Masataka Uehara et al.
ORAL ONCOLOGY (2009)
被撤回的出版物: Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells (Retracted article. See vol. 119, 2022)
KangAe Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1α expression in colon carcinoma cells
Hongzhong Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Sunitinib therapy in renal cell carcinoma
Matthew F. O'Brien et al.
BJU INTERNATIONAL (2008)
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo
Christian Moser et al.
BMC CANCER (2008)
Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo
H. Yasui et al.
BRITISH JOURNAL OF CANCER (2008)
Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2
H. J. Choi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo
Daniel Cejka et al.
CANCER BIOLOGY & THERAPY (2008)
HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma
John D. Gordan et al.
CANCER CELL (2008)
A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy
Sandra Turcotte et al.
CANCER CELL (2008)
Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells
Maura Calvani et al.
CANCER RESEARCH (2008)
TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis
Lihua Zeng et al.
CANCER SCIENCE (2008)
EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1
Shala L. Thomas et al.
CELL CYCLE (2008)
Expression of hypoxia-inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma
Ching Tzao et al.
DISEASE MARKERS (2008)
Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts
Esther G. C. Troost et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts
H. Manabe et al.
INFLAMMATION RESEARCH (2008)
PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells
Sanjeewani T. Palayoor et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
PROGNOSTIC SIGNIFICANCE OF TUMOR HYPOXIA INDUCIBLE FACTOR-1α EXPRESSION FOR OUTCOME AFTER RADIOTHERAPY IN OROPHARYNGEAL CANCER
Priyamal Silva et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Overexpression of hypoxia-inducible factor-1α predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract
Hung-Lung Ke et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
In vivo and in vitro effects of a HIF-1α inhibitor, RX-0047
Z. Gunnur Dikmen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
A23187, lonomycin and thapsigargin upregulate mRNA of HIP-1 alpha via endoplasmic reticulum stress rather than a rise in intracellular calcium
Christian Werno et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1 alpha
Mei Y. Koh et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Shan Hua Li et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Lee M. Greenberger et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
Theresa M. LaVallee et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1α and -2α
Maura Puppo et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by akt inhibition in human prostate carcinoma PC3-M cells
Salida Mirzoeva et al.
MOLECULAR CARCINOGENESIS (2008)
Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice
E. B. Rankin et al.
ONCOGENE (2008)
Expression of hypoxia-inducible factor-1α, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma
Kotaro Miyake et al.
PANCREAS (2008)
Paclitaxel induces vascular endothelial growth factor expression through reactive oxygen species production
Hyun Sun Kim et al.
PHARMACOLOGY (2008)
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Huafeng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen
Archana Bommi-Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation
Xiaoyu Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer
Byung Lan Lee et al.
CARCINOGENESIS (2008)
Hypoxia-inducible factor 1α in clear cell renal cell carcinoma
Tobias Klatte et al.
CLINICAL CANCER RESEARCH (2007)
Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor
Chang Xia et al.
CANCER RESEARCH (2007)
Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells
Adrian Staab et al.
BMC CANCER (2007)
Dual effect of echinomycin on hypoxia-inducible factor-1 activity under normoxic and hypoxic conditions
Benoit Vlaminck et al.
FEBS JOURNAL (2007)
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth
Sven A. Lang et al.
CLINICAL CANCER RESEARCH (2007)
UVC inhibits HIF-1α protein translation by a DNA damage- and topoisomerase I-independent pathway
A. Rapisarda et al.
ONCOGENE (2007)
Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α
Yang Lu et al.
MOLECULAR CANCER (2007)
Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene:: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
Ryosuke Osada et al.
HUMAN PATHOLOGY (2007)
Detection and characterization of tumor hypoxia using pO2 histography
Peter Vaupel et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
Seiji Mabuchi et al.
CLINICAL CANCER RESEARCH (2007)
Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells
Monique C. A. Duyndam et al.
BIOCHEMICAL PHARMACOLOGY (2007)
YC-1 inhibits HIF-1 expression in prostate cancer cells:: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia
H-L Sun et al.
ONCOGENE (2007)
Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1
K. M. Sutton et al.
ONCOGENE (2007)
Hypoxia-inducible factor-1α correlates with MET and metastasis in node-negative breast cancer
Helen H. W. Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1) -: A negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells
Yuichi Makino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression
Jing Fang et al.
CARCINOGENESIS (2007)
Imaging oxygenation of human tumours
Anwar R. Padhani et al.
EUROPEAN RADIOLOGY (2007)
HIF-1α and CA IX staining in invasive breast carcinomas:: Prognosis and treatment outcome
Cynthia Trastour et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
Mutant V600E BRAF increases hypoxia inducible factor-1α expression in melanoma
Suresh M. Kumar et al.
CANCER RESEARCH (2007)
Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells
Qiu Zhao et al.
PANCREAS (2007)
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Abderrahmane Kaidi et al.
NATURE CELL BIOLOGY (2007)
Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1α protein accumulation by NSC 644221
Mark Creighton-Gutteridge et al.
CLINICAL CANCER RESEARCH (2007)
RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α
Ye V. Liu et al.
MOLECULAR CELL (2007)
Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1α and Hdm2
Gretchen A. LaRusch et al.
CANCER RESEARCH (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation
Jean-Jacques Briere et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
HIV protease inhibitors decrease VEGF/HIF-1α expression and angiogenesis in glioblastoma cells
Nabendu Pore et al.
NEOPLASIA (2006)
Suppression of hypoxia inducible factor-1α (HIF-1α) by YC-1 is dependent on murine double minute 2 (Mdm2)
Chi Keung Lau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer
Joseph G. Rajendran et al.
CLINICAL CANCER RESEARCH (2006)
Nelfinavir down-regulates hypoxia-inducible factor 1α and VEGF expression and increases tumor oxygenation:: Implications for radiotherapy
Nabendu Pore et al.
CANCER RESEARCH (2006)
Overexpression of hypoxia-inducible factor 1α and p53 is a marker for an unfavorable prognosis in gastric cancer
Yasushi Sumiyoshi et al.
CLINICAL CANCER RESEARCH (2006)
Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding
Dylan T. Jones et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The relation between hypoxia-inducible factor (HIF)-1α and HIF-2α expression with anemia and outcome in surgically treated head and neck cancer
Stuart C. Winter et al.
CANCER (2006)
Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1
Eun Jung Park et al.
CELL CYCLE (2006)
Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients
Daniela Thorwarth et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Inhibition of angiogenesis and HIF-1α activity by antimycin A1
Masayuki Maeda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1α in human salivary gland cancer cells
Shingo Hara et al.
ORAL ONCOLOGY (2006)
Role of hypoxia-inducible factor (HIF)-1α-versus HIF-2α in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-1, or loss of von Hippel-Lindau function:: Implications for targeting the HIF pathway
Veronica A. Carroll et al.
CANCER RESEARCH (2006)
Effects of geldanamycin on HIF-1α mediated angiogenesis and invasion in prostate cancer cells
O. Alqawi et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis
R. H. Giles et al.
ONCOGENE (2006)
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-α
DM Fath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CCl-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1α/VEGF signaling
Xiaolin Wan et al.
NEOPLASIA (2006)
Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1α) and HIF-2α in stem cells
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms
N Pore et al.
CANCER RESEARCH (2006)
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer:: a feasibility study -: art. no. 51
B Gagel et al.
BMC CANCER (2006)
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase II placebo-controlled randomized discontinuation trial of sorafnib in patients with metastatic renal cell carcinoma
Mark J. Ratain et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Metabolite changes in HT-29 xenograft tumors following HIF-1α inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo
NF Jordan et al.
NMR IN BIOMEDICINE (2005)
Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1α is involved in trophoblast invasion under low-oxygen tension
M Hayashi et al.
ENDOCRINOLOGY (2005)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
Mdm2 and HIF-1α interaction in tumor cells during hypoxia
AL Nieminen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity
BJ Moeller et al.
CANCER CELL (2005)
The HIF pathway in cancer
PH Maxwell
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor
T Fillies et al.
BMC CANCER (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1α expression in human glioma cells by a proteasome-independent pathway:: Implications for in vivo therapy
EW Newcomb et al.
NEURO-ONCOLOGY (2005)
p53 mutation heterogeneity in cancer
T Soussi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression
RB Luwor et al.
ONCOGENE (2005)
Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1α induction in response to hypoxic stress and growth factors
NM Chau et al.
CANCER RESEARCH (2005)
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1α using PX-478
BF Jordan et al.
NEOPLASIA (2005)
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
KJ Williams et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Genistein inhibited hypoxia-inducible factor-1α expression induced by hypoxia and cobalt chloride in human retinal pigment epithelium cells
B Wang et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2005)
Anti-angiogenic effects of SN38 (active metabolite of irinotecan):: inhibition of hypoxia-inducible factor 1 alpha (HIF-1α)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells
H Kamiyama et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Targeted replacement of hypoxia-inducible factor-1α by a hypoxia-inducible factor-2α knock-in allele promotes tumor growth
KL Covello et al.
CANCER RESEARCH (2005)
Imaging hypoxia and angiogenesis in tumors
JG Rajendran et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2005)
Binding of natively unfolded HIF-1α ODD domain to p53
N Sánchez-Puig et al.
MOLECULAR CELL (2005)
Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma
SP Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Hypoxia-inducible factor-1 and oncogenic signalling
JI Bárdos et al.
BIOESSAYS (2004)
Apigenin suppresses the expression of VEGF, an important factor for anglogenesis, in endothelial cells via degradation of HIF-1α protein
M Osada et al.
FEBS LETTERS (2004)
New anticancer strategies targeting HIF-1
EJ Yeo et al.
BIOCHEMICAL PHARMACOLOGY (2004)
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584
DZ Qian et al.
CANCER RESEARCH (2004)
Ras-dependent induction of HIF-1a785 via the Raf/MEK/ERK pathway:: a novel mechanism of Ras-mediated tumor promotion
JH Lim et al.
ONCOGENE (2004)
2-methoxyestradiol inhibits hypoxia-inducible factor lot, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma
JL Ricker et al.
CLINICAL CANCER RESEARCH (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
AL Kung et al.
CANCER CELL (2004)
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
BZ Olenyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
NS398 reduces hypoxia-inducible factor (HIF)-1α and HIF-1 activity:: Multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms
H Zhong et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia
K Nakayama et al.
CELL (2004)
Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression
P Buchler et al.
CANCER (2004)
Small molecule-mediated anti-cancer therapy via hypoxia-inducible factor-1 blockade
GR Macpherson et al.
CANCER BIOLOGY & THERAPY (2004)
p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1)
T Schmid et al.
BIOCHEMICAL JOURNAL (2004)
Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts
A Rapisarda et al.
CANCER RESEARCH (2004)
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
G Gruber et al.
BREAST CANCER RESEARCH (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Redistribution of intracellular oxygen in hypoxia by nitric oxide:: Effect on HIF1α
T Hagen et al.
SCIENCE (2003)
Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of anglogenesis factors
Y Sasakawa et al.
BIOCHEMICAL PHARMACOLOGY (2003)
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia
E Berra et al.
EMBO JOURNAL (2003)
Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo
Y Sasakawa et al.
CANCER LETTERS (2003)
Direct interactions between HIF-1α and Mdm2 modulate p53 function
DL Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
Estimating hypoxic status in human tumors: A simulation using Eppendorf oxygen probe data in cervical cancer patients
CM Doll et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Dominant-negative hypoxia-inducible factor-1α reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism
J Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 uhiquitin ligase complex
MA Maynard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma
R Bos et al.
CANCER (2003)
Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity
YM Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Mechanism of action of 2-methoxyestradiol: new developments
SL Mooberry
DRUG RESISTANCE UPDATES (2003)
Novel cancer therapy by reactivation of the p53 apoptosis pathway
VJN Bykov et al.
ANNALS OF MEDICINE (2003)
Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography-computerized tomography Imaging
A Brahme
ACTA ONCOLOGICA (2003)
Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1α expression under normoxia
R Karni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803
LA McNeill et al.
BIOCHEMICAL JOURNAL (2002)
Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells
R Fukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer
MI Koukourakis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family
KS Hewitson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
D Lando et al.
GENES & DEVELOPMENT (2002)
Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
D Lando et al.
SCIENCE (2002)
Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression
Y Makino et al.
NATURE (2001)
A conserved family of prolyl-4-hydroxylases that modify HIF
RK Bruick et al.
SCIENCE (2001)
Regulation of the hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide
KB Sandau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Hypoxia in human prostate carcinoma -: An Eppendorf Po2 study
B Movsas et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)
Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation
N Masson et al.
EMBO JOURNAL (2001)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Levels of hypoxia-inducible factor-1α during breast carcinogenesis
R Bos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Suppression of tumor growth through disruption of hypoxia-inducible transcription
AL Kung et al.
NATURE MEDICINE (2000)
Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
M Krieg et al.
ONCOGENE (2000)
Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI3K pathway
KB Sandau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia
NC Denko et al.
EXPERIMENTAL CELL RESEARCH (2000)
MAP kinases and hypoxia in the control of VEGF expression
E Berra et al.
CANCER AND METASTASIS REVIEWS (2000)
Share Paper
